Czech Minister wants to extend non-Rxing

13 February 2006

Czech Health Minister David Rath has said he wants to extend the sales of non-prescription drugs and is examining whether this policy would only require an administrative change to bring it into operation. He also stated that he would like to enable direct supplies of drugs to be allotted to hospitals without the mediation of pharmacies. The proposed changes are now the subject of internal parliamentary committees debate.

Meanwhile, Dr Rath has refused any concessions as nearly 2,000 pharmacies across the nation closed in protest over a reduction in their margins from 32% to 29%. Pharmacists claim this threatens their existence. For his part, the Minister has described the protest as a "strike by millionaires," saying their proposal to raise margins to 50% on lower cost drugs was unacceptable.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK





Today's issue

Company Spotlight